Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
decades, LBMM has developed powerful technology platforms in the field of biomedicine and genomics, also resulting in the establishment of two startup companies (www.veraxa.de and www.thera-me.ch ) and a
-
Abstractions Lab (LASeR) develops programming languages and formal reasoning tools for networked systems. Networks are the invisible infrastructure that connects the modern world, yet programming and reasoning
-
imaging, high-content, single-cell resolution) to assay compound activity Develop imaging assays capable of distinguishing mechanism of action (e.g. growth inhibition, biofilm/attachment disruption
-
conducts applied and theoretical research on the economics and politics of sustainable development, as well as the policies to achieve it. More information at: https://www.epfl.ch/labs/pasu/ . We are looking
-
political implications of vertical urban development. The project has three main ambitions: (1) developing methods to measure verticality and its impacts in data-scarce contexts, in Africa and elsewhere; (2
-
these questions using populations and species sampled along elevational gradients, providing a powerful framework for identifying the causes of species' range limits and understanding constraints on the evolution
-
, demonstrating that AI can help make verified systems competitive with unverified systems in terms of development effort, features, and performance. Main duties and responsibilities Conducting research related
-
by Prof. Marc Gruber, within EPFL's College of Management of Technology. You will have scope to develop your own research agenda and to collaborate with Prof. Gruber and the Chair's researchers
-
. The research project focuses on the development of solid electrode composites, so-called boosters, for next-generation redox-targeted flow batteries. In these systems, soluble redox mediators dissolved in
-
tumor evolution requires integrating both genetic and non-genetic mechanisms. Thus, our research begins with the functional characterization of cancer-associated genomic alterations to determine how they